{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:35:08Z","timestamp":1785443708948,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"DOI":"10.1186\/s12245-024-00691-5","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T08:02:18Z","timestamp":1725264138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cytokine release syndrome following COVID-19 infection during treatment with nivolumab for cancer of esophagogastric junction carcinoma: a case report and review"],"prefix":"10.1186","volume":"17","author":[{"given":"Takahisa","family":"Niimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Todaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Hoashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"691_CR1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.idc.2022.07.001","volume":"36","author":"J Athale","year":"2022","unstructured":"Athale J, Busch LM, O\u2019Grady NP. Cytokine Release Syndrome and Sepsis: Analogous Clinical Syndromes with Distinct Causes and Challenges in Management. Infect Dis Clin North Am. 2022;36:735\u201348.","journal-title":"Infect Dis Clin North Am"},{"key":"691_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.807050","volume":"13","author":"SH Tay","year":"2022","unstructured":"Tay SH, Toh MMX, Thian YL, Vellayappan BA, Fairhurst AM, Chan YH, et al. Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature. Front Immunol. 2022;13: 807050.","journal-title":"Front Immunol"},{"key":"691_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.6004\/jnccn.2022.0020","volume":"20","author":"JA Thompson","year":"2022","unstructured":"Thompson JA, Schneider BJ, Brahmer J, Achufusi A, Armand P, Berkenstock MK, et al. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20:387\u2013405.","journal-title":"J Natl Compr Canc Netw."},{"key":"691_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40425-019-0582-4","volume":"7","author":"O Honjo","year":"2019","unstructured":"Honjo O, Kubo T, Sugaya F, Nishizaka T, Kato K, Hirohashi Y, et al. Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report. J Immunother Cancer. 2019;7:97.","journal-title":"J Immunother Cancer"},{"key":"691_CR5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.9531","author":"RD Carvajal","year":"2021","unstructured":"Carvajal RD, Sato T, Butler MO, Sacco JJ, Shoushtari AN, Hassel JC, et al. Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in patients (pts) with previously treated (2L+) metastatic uveal melanoma(mUM). J Clin Oncol. 2021. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.9531.","journal-title":"J Clin Oncol"},{"key":"691_CR6","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.926433","volume":"21","author":"I Dumic","year":"2020","unstructured":"Dumic I, Radovanovic M, Igandan O, Savic I, Nordstrom CW, Jevtic D, et al. A Fatal Case of Kaposi Sarcoma Immune Reconstitution Syndrome (KS-IRIS) Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS) or Multicentric Castleman Disease (MCD): A Case Report and Review. Am J Case Rep. 2020;21: e926433.","journal-title":"Am J Case Rep"},{"key":"691_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3322\/caac.21596","volume":"70","author":"LB Kennedy","year":"2020","unstructured":"Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70:86\u2013104.","journal-title":"CA Cancer J Clin"},{"key":"691_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","volume":"16","author":"F Martins","year":"2019","unstructured":"Martins F, Sofiya L, Sykiotis GP, Lamine F, Maillard M, Fraga M, et al. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat Rev Clin Oncol. 2019;16:563\u201380.","journal-title":"Nat Rev Clin Oncol"},{"key":"691_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fphar.2020.00557","volume":"11","author":"A Ceschi","year":"2020","unstructured":"Ceschi A, Noseda R, Palin K, Verhamme K. Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database. Front Pharmacol. 2020;11:557.","journal-title":"Front Pharmacol"},{"key":"691_CR10","first-page":"56","volume":"6","author":"A Shimabukuro-Vornhagen","year":"2018","unstructured":"Shimabukuro-Vornhagen A, G\u00f6del P, Subklewe M, Stemmler HJ, Schl\u00f6\u00dfer HA, Schlaak M, et al. Cytokine release syndrome. J Immunother. Cancer. 2018;6:56.","journal-title":"Cancer"},{"key":"691_CR11","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/08971900211000691","volume":"35","author":"J Meanwatthana","year":"2022","unstructured":"Meanwatthana J, Majam T. Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection. J Pharm Pract. 2022;35:752\u201361.","journal-title":"J Pharm Pract"},{"key":"691_CR12","volume":"3","author":"K Kunimasa","year":"2021","unstructured":"Kunimasa K, Inoue T, Matsueda K, Kawamura T, Tamiya M, Nishino K, Kumagai T. Cytokine Release Syndrome and Immune-Related Pneumonitis Associated With Tumor Progression in a Pulmonary Pleomorphic Carcinoma Treated With Nivolumab Plus Ipilimumab Treatment: A Case Report. JTO Clin Res Rep. 2021;3: 100272.","journal-title":"JTO Clin Res Rep"},{"key":"691_CR13","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.cmi.2021.08.015","volume":"27","author":"XJ Xu","year":"2021","unstructured":"Xu XJ, Zhao FY, Tang YM. Fulminant cytokine release syndrome in a paediatric patient with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis receiving nivolumab treatment. Clin Microbiol Infect. 2021;27:1710\u20132.","journal-title":"Clin Microbiol Infect"},{"key":"691_CR14","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3115-23","author":"K Yamamoto","year":"2024","unstructured":"Yamamoto K, Shiotsu S, Sasakura M, Tanaka S, Goda S, Tsuji T, et al. Cytokine Release Syndrome with Relative Adrenal Insufficiency Induced by Ipilimumab and Nivolumab Combination Therapy for Clear Cell Renal Cell Carcinoma. Intern Med. 2024. https:\/\/doi.org\/10.2169\/internalmedicine.3115-23.","journal-title":"Intern Med"},{"key":"691_CR15","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1111\/1759-7714.14632","volume":"13","author":"D Murata","year":"2022","unstructured":"Murata D, Azuma K, Tokisawa S, Tokito T, Hoshino T. A case of cytokine release syndrome accompanied with COVID-19 infection during treatment with immune checkpoint inhibitors for non-small cell lung cancer. Thorac Cancer. 2022;13:2911\u20134.","journal-title":"Thorac Cancer"},{"key":"691_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/CJI.0000000000000440","volume":"45","author":"M Guo","year":"2022","unstructured":"Guo M, Liu J, Miao R, Ahmed Z, Yu J, Guan J, et al. A Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors. J Immunother. 2022;45:389\u201395.","journal-title":"J Immunother"},{"key":"691_CR17","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.21037\/tlcr-22-388","volume":"11","author":"T Sumi","year":"2022","unstructured":"Sumi T, Koshino Y, Michimata H, Nagayama D, Watanabe H, Yamada Y, Chiba H. Cytokine release syndrome in a patient with non-small cell lung cancer on ipilimumab and nivolumab maintenance therapy after vaccination with the mRNA-1273 vaccine: a case report. Transl Lung Cancer Res. 2022;11:1973\u20136.","journal-title":"Transl Lung Cancer Res"},{"key":"691_CR18","doi-asserted-by":"crossref","unstructured":"van der Veldt AAM, Oosting SF, Dingemans AC, Fehrmann RSN, GeurtsvanKessel, Jalving M, et al. COVID-19 vaccination: the VOICE for patients with cancer. Nat Med 2021;27:568\u20139.","DOI":"10.1038\/s41591-021-01240-w"},{"key":"691_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100410","volume":"24","author":"A Mastroianni","year":"2020","unstructured":"Mastroianni A, Greco S, Apuzzo G, De Santis S, Oriolo C, Zanolini A, et al. Subcutaneous tocilizumab treatment in patients with severe COVID-19-related cytokine release syndrome: An observational cohort study. EClinicalMedicine. 2020;24: 100410.","journal-title":"EClinicalMedicine"},{"key":"691_CR20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2169\/internalmedicine.2429-23","volume":"63","author":"T Tanaka","year":"2024","unstructured":"Tanaka T, Taoka M, Makimoto G, Ninomiya K, Higo H, Fujii M, et al. Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer. Intern Med. 2024;63:1261\u20137.","journal-title":"Intern Med"},{"key":"691_CR21","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.941835","volume":"25","author":"F Ntwali","year":"2024","unstructured":"Ntwali F, Gilliaux Q, Honor\u00e9 PM. Nivolumab-Induced Cytokine Release Syndrome: A Case Report and Literature Review. Am J Case Rep. 2024;25: e941835.","journal-title":"Am J Case Rep"},{"key":"691_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jtho.2023.10.010","volume":"19","author":"Y Shiraishi","year":"2024","unstructured":"Shiraishi Y, Tokito T, Toyozawa R, Inagaki C, Nokihara H, Kawashima Y, et al. Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic Chemotherapy Together With Nivolumab Plus Ipilimumab: A Case Report. J Thorac Oncol. 2024;19:337\u201343.","journal-title":"J Thorac Oncol"},{"key":"691_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/JBM.S444004","volume":"15","author":"O Mosalem","year":"2024","unstructured":"Mosalem O, Pai T, Alqawasma M, Shaikh M, Li KD, Alhaj MM. Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. J Blood Med. 2024;15:29\u201334.","journal-title":"J Blood Med"},{"key":"691_CR24","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1111\/1759-7714.15015","volume":"14","author":"T Tsutsui","year":"2023","unstructured":"Tsutsui T, Hata K, Kawaguchi M, Kobayashi H, Kakizaki Y, Miyashita Y. Cytokine release syndrome complicated with severe rashes induced by nivolumab plus ipilimumab therapy in a patient with non-small cell lung cancer: A case report. Thorac Cancer. 2023;14:2310\u20133.","journal-title":"Thorac Cancer"},{"key":"691_CR25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1159\/000525173","volume":"15","author":"SR Menakuru","year":"2022","unstructured":"Menakuru SR, Azeem Q, Priscu A, Khan I, Beirat A. Stage 4 Cytokine Release Syndrome Caused by the First Dose of Nivolumab and Ipilimumab Combination Therapy in a Patient with Metastatic Melanoma Successfully Treated with Methylprednisolone, Tocilizumab, and Etanercept. Case Rep Oncol. 2022;15:648\u201353.","journal-title":"Case Rep Oncol"},{"key":"691_CR26","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.12998\/wjcc.v10.i5.1580","volume":"10","author":"PB Deng","year":"2022","unstructured":"Deng PB, Jiang J, Hu CP, Cao LM, Li M. Tumor-related cytokine release syndrome in a treatment-na\u00efve patient with lung adenocarcinoma: A case report. World J Clin Cases. 2022;10:1580\u20135.","journal-title":"World J Clin Cases"},{"key":"691_CR27","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2217\/imt-2020-0329","volume":"13","author":"AT Ciner","year":"2021","unstructured":"Ciner AT, Hochster HS, August DA, Carpizo DR, Spencer KR. Delayed cytokine release syndrome after neoadjuvant nivolumab: a case report and literature review. Immunotherapy. 2021;13:1071\u20138.","journal-title":"Immunotherapy"},{"key":"691_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019741","volume":"99","author":"J Ohira","year":"2020","unstructured":"Ohira J, Kawamoto M, Sugino Y, Kohara N. A case report of fulminant cytokine release syndrome complicated by dermatomyositis after the combination therapy with immune checkpoint inhibitors. Medicine (Baltimore). 2020;99: e19741.","journal-title":"Medicine (Baltimore)"},{"key":"691_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/ejh.13248","volume":"103","author":"A Sindel","year":"2019","unstructured":"Sindel A, Taylor T, Chesney A, Clark W, Fowler AA 3rd, Toor AA. Hematopoietic stem cell mobilization following PD-1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid. Eur J Haematol. 2019;103:134\u20136.","journal-title":"Eur J Haematol"},{"key":"691_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000496933","volume":"12","author":"H Oda","year":"2019","unstructured":"Oda H, Ishihara M, Miyahara Y, Nakamura J, Kozuka Y, Iwasa M, et al. First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer. Case Rep Oncol. 2019;12:147\u201356.","journal-title":"Case Rep Oncol"},{"key":"691_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2217\/imt-2018-0025","volume":"10","author":"L Zhao","year":"2018","unstructured":"Zhao L, Yang Y, Li W, Li T, Gao Q. Nivolumab-induced cytokine-release syndrome in relapsed\/refractory Hodgkin\u2019s lymphoma: a case report and literature review. Immunotherapy. 2018;10:913\u20137.","journal-title":"Immunotherapy"},{"key":"691_CR32","doi-asserted-by":"publisher","unstructured":"Rotz SJ, Leino D, Szabo S, Mangino JL, Turpin BK, Pressey JG. Severe cytokine release syndrome in a patient receiving PD-1-directed therapy. Pediatr Blood Cancer. 2017;64(12). https:\/\/doi.org\/10.1002\/pbc.26642. Epub 2017 May 24.","DOI":"10.1002\/pbc.26642"},{"key":"691_CR33","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1097\/MPH.0000000000000703","volume":"39","author":"AE Foran","year":"2017","unstructured":"Foran AE, Nadel HR, Lee AF, Savage KJ, Deyell RJ. Nivolumab in the Treatment of Refractory Pediatric Hodgkin Lymphoma. J Pediatr Hematol Oncol. 2017;39:e263\u20136.","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-024-00691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12245-024-00691-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-024-00691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T08:03:21Z","timestamp":1725264201000},"score":1,"resource":{"primary":{"URL":"https:\/\/intjem.biomedcentral.com\/articles\/10.1186\/s12245-024-00691-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["691"],"URL":"https:\/\/doi.org\/10.1186\/s12245-024-00691-5","relation":{},"ISSN":["1865-1380"],"issn-type":[{"value":"1865-1380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"18 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}